ATA527980A - Loesungsmittelgemisch und verfahren zur herstellung von stabilen waesserigen loesungen von eburnamenin- und/oder dihydroeburnameninderivaten und verfahren zur herstellung von solchen loesungen - Google Patents
Loesungsmittelgemisch und verfahren zur herstellung von stabilen waesserigen loesungen von eburnamenin- und/oder dihydroeburnameninderivaten und verfahren zur herstellung von solchen loesungenInfo
- Publication number
- ATA527980A ATA527980A AT0527980A AT527980A ATA527980A AT A527980 A ATA527980 A AT A527980A AT 0527980 A AT0527980 A AT 0527980A AT 527980 A AT527980 A AT 527980A AT A527980 A ATA527980 A AT A527980A
- Authority
- AT
- Austria
- Prior art keywords
- producing
- solutions
- dihydroeburname
- eburnamenine
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU79RI733A HU181940B (en) | 1979-11-02 | 1979-11-02 | Process for producing solutions of vincane derivatives for parentheral application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA527980A true ATA527980A (de) | 1984-10-15 |
| AT377914B AT377914B (de) | 1985-05-28 |
Family
ID=11001115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0527980A AT377914B (de) | 1979-11-02 | 1980-10-27 | Loesungsmittelgemisch zur herstellung von stabilen waesserigen loesungen von eburnameninund/oder dihydroeburnameninderivaten und verfahren zur herstellung von solchen loesungen |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4344950A (de) |
| JP (1) | JPS56123911A (de) |
| AR (1) | AR223735A1 (de) |
| AT (1) | AT377914B (de) |
| AU (1) | AU533715B2 (de) |
| BE (1) | BE885987A (de) |
| CA (1) | CA1159367A (de) |
| CH (1) | CH645019A5 (de) |
| CS (1) | CS226417B2 (de) |
| DD (1) | DD153760A5 (de) |
| DE (1) | DE3041368A1 (de) |
| DK (1) | DK464680A (de) |
| FI (1) | FI803401A7 (de) |
| FR (1) | FR2468373A1 (de) |
| GB (1) | GB2062464B (de) |
| HU (1) | HU181940B (de) |
| IL (1) | IL61310A (de) |
| IT (1) | IT1209367B (de) |
| NL (1) | NL8005980A (de) |
| NO (1) | NO803254L (de) |
| PH (1) | PH17037A (de) |
| SE (1) | SE8007569L (de) |
| YU (1) | YU278880A (de) |
| ZA (1) | ZA806468B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1170152B (it) * | 1982-07-19 | 1987-06-03 | Lilly Co Eli | Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi |
| US4619935A (en) * | 1983-03-17 | 1986-10-28 | Eli Lilly And Company | Stable oncolytic formulations |
| US5360593A (en) * | 1987-12-29 | 1994-11-01 | Alcon Laboratories, Inc. | Heat sterilization of labile antibiotics |
| CN101721361B (zh) * | 2009-12-08 | 2013-06-26 | 李荣立 | 长春胺注射剂及其制备工艺 |
| CN112649522B (zh) * | 2020-11-30 | 2022-02-22 | 海南葫芦娃药业集团股份有限公司 | 一种注射液中有关物质长春胺酸与阿朴长春胺酸的检测方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3005754A (en) * | 1957-08-16 | 1961-10-24 | Bristol Myers Co | Tetracycline formulations |
| US3155586A (en) * | 1963-01-23 | 1964-11-03 | American Cyanamid Co | Stable liquid preparations of 6-demethyltetracyclines |
| US3159542A (en) * | 1962-12-31 | 1964-12-01 | American Cyanamid Co | Stable aqueous glycol solution of tetracycline aluminum calcium gluconate complex having a ph of about 7. 5 to 9 |
| GB1005342A (en) * | 1963-01-23 | 1965-09-22 | Olin Mathieson | Pharmaceutical preparations containing choline ester salts |
| FR2191891B1 (de) * | 1972-07-13 | 1975-08-08 | Roussel Uclaf | |
| FR2279394A2 (fr) * | 1973-12-13 | 1976-02-20 | Saunier Laboratoires | Medicament pour le traitement des insuffisances circulatoires cerebrales |
-
1979
- 1979-11-02 HU HU79RI733A patent/HU181940B/hu unknown
-
1980
- 1980-10-20 IL IL61310A patent/IL61310A/xx unknown
- 1980-10-21 ZA ZA00806468A patent/ZA806468B/xx unknown
- 1980-10-23 CS CS807199A patent/CS226417B2/cs unknown
- 1980-10-27 AT AT0527980A patent/AT377914B/de not_active IP Right Cessation
- 1980-10-28 US US06/201,509 patent/US4344950A/en not_active Expired - Lifetime
- 1980-10-28 SE SE8007569A patent/SE8007569L/ unknown
- 1980-10-30 YU YU02788/80A patent/YU278880A/xx unknown
- 1980-10-30 FI FI803401A patent/FI803401A7/fi not_active Application Discontinuation
- 1980-10-31 BE BE0/202670A patent/BE885987A/fr not_active IP Right Cessation
- 1980-10-31 FR FR8023347A patent/FR2468373A1/fr active Granted
- 1980-10-31 DK DK464680A patent/DK464680A/da not_active Application Discontinuation
- 1980-10-31 CA CA000363725A patent/CA1159367A/en not_active Expired
- 1980-10-31 JP JP15235880A patent/JPS56123911A/ja active Pending
- 1980-10-31 DD DD80224849A patent/DD153760A5/de unknown
- 1980-10-31 NO NO803254A patent/NO803254L/no unknown
- 1980-10-31 AR AR283093A patent/AR223735A1/es active
- 1980-10-31 AU AU64004/80A patent/AU533715B2/en not_active Ceased
- 1980-10-31 CH CH813580A patent/CH645019A5/de not_active IP Right Cessation
- 1980-10-31 NL NL8005980A patent/NL8005980A/nl not_active Application Discontinuation
- 1980-10-31 IT IT8025683A patent/IT1209367B/it active
- 1980-10-31 GB GB8035112A patent/GB2062464B/en not_active Expired
- 1980-11-02 PH PH24934A patent/PH17037A/en unknown
- 1980-11-03 DE DE19803041368 patent/DE3041368A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| PH17037A (en) | 1984-05-17 |
| FR2468373A1 (fr) | 1981-05-08 |
| DK464680A (da) | 1981-05-03 |
| FI803401L (fi) | 1981-05-03 |
| JPS56123911A (en) | 1981-09-29 |
| AU533715B2 (en) | 1983-12-08 |
| AT377914B (de) | 1985-05-28 |
| IT1209367B (it) | 1989-07-16 |
| CH645019A5 (de) | 1984-09-14 |
| HU181940B (en) | 1983-11-28 |
| IL61310A0 (en) | 1980-12-31 |
| AU6400480A (en) | 1981-05-07 |
| US4344950A (en) | 1982-08-17 |
| FI803401A7 (fi) | 1981-05-03 |
| FR2468373B1 (de) | 1984-12-28 |
| NL8005980A (nl) | 1981-06-01 |
| CS226417B2 (en) | 1984-03-19 |
| YU278880A (en) | 1984-04-30 |
| BE885987A (fr) | 1981-02-16 |
| AR223735A1 (es) | 1981-09-15 |
| SE8007569L (sv) | 1981-05-03 |
| CA1159367A (en) | 1983-12-27 |
| DE3041368A1 (de) | 1981-05-14 |
| IL61310A (en) | 1984-08-31 |
| NO803254L (no) | 1981-05-04 |
| IT8025683A0 (it) | 1980-10-31 |
| DD153760A5 (de) | 1982-02-03 |
| GB2062464A (en) | 1981-05-28 |
| ZA806468B (en) | 1981-10-28 |
| GB2062464B (en) | 1983-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT376979B (de) | Verfahren zur herstellung von 4-pyridon-3carbons[uren und/oder deren derivaten | |
| AT367745B (de) | Verfahren zur herstellung von neuen substituierten 4-sulfonylaminophenoxyalkancarbonsaeuren und derenderivaten | |
| AT375646B (de) | Verfahren zur herstellung von neuen sulfonamidopyridinderivaten und deren salzen | |
| AT354624B (de) | Verfahren zur herstellung von clavulansaeure und deren salzen | |
| AT361464B (de) | Verfahren zur herstellung von neuen derivaten von perhydro-aza-heterocyclen und ihren saeure- additionssalzen | |
| DD135905A5 (de) | Verfahren zur herstellung von harnstoffderivaten | |
| AT359994B (de) | Verfahren zur herstellung von neuen benzoe- saeurederivaten und acylophenonen | |
| DD128562A5 (de) | Verfahren zur herstellung von 7-methoxy-cephalosporinen und deren salzen | |
| DD132429A5 (de) | Verfahren zur herstellung von derivaten von phenoxyalkansaeuren | |
| ATA527980A (de) | Loesungsmittelgemisch und verfahren zur herstellung von stabilen waesserigen loesungen von eburnamenin- und/oder dihydroeburnameninderivaten und verfahren zur herstellung von solchen loesungen | |
| AT358583B (de) | Verfahren zur herstellung von neuen piperidy- lidenderivaten von benzoxanthenen und deren saeureadditionssalzen | |
| DD134871A5 (de) | Verfahren zur herstellung von pyrrolochinoxalinonen und pyrrolobenzdiazepinonen | |
| AT358163B (de) | Verfahren zur herstellung detoxifizierter zubereitungen von cytostatika | |
| AT370418B (de) | Verfahren zur herstellung von derivaten der 7-aminothiazolylacetamidocephalosporansaeure | |
| AT348524B (de) | Verfahren zur herstellung von neuen naphthyridinderivaten und von deren saeureadditionssalzen | |
| DD139255A5 (de) | Verfahren zur herstellung von(omega-aminoalkoxy)-bibenzylen und ihrer saeureadditionssalze | |
| AT373914B (de) | Verfahren zur stereospezifischen herstellung von d-carbamylderivaten von alpha-hydroxysaeuren | |
| ATA39679A (de) | Verfahren zur herstellung von ergopeptidalkaloid -derivaten | |
| DD129785A5 (de) | Verfahren zur herstellung von indazolderivaten | |
| DD135485A5 (de) | Verfahren zur herstellung von nitroalkanolderivaten | |
| DD132430A1 (de) | Verfahren zur herstellung von halbestern und halbamiden substituierter malonsaeuren | |
| DD132660A5 (de) | Verfahren zur herstellung von malonylharnstoffderivaten | |
| ATA851675A (de) | Verfahren zur herstellung von 1-phenyl-2-glycinamidoathanolen- (1) und von deren salzen | |
| ATA45677A (de) | Verfahren zur herstellung von 4-desacetoxy- -vinblastin und dessen saeureadditionssalzen | |
| DD133236A1 (de) | Verfahren zur herstellung von 2-phenyl-3-furyl-2-propensaeure und deren derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |